Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Discover the crucial years to consider for retirement planning. Equip yourself with strategies for a successful retirement.
21,887 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Institutional hands move in the ETF space as second line capital buys into a short-maturity strategy. This article br...
A china-focused fund cuts million from Mattel in a first-quarter move. This article explains why such moves happen, w...
A notable fund sold a sizable stake in a leading pet-food company, triggering questions about motive, timing, and imp...
FedEx recently spun off its FedEx Freight unit, creating two focused companies. This article explains what that move ...
Niche energy tech stocks can surge on fresh coverage and bullish notes. This guide explains why the nano nuclear ener...
Investors are weighing SpaceX's first earnings as a public company against a backdrop of limited float and big hype. ...
When netflix stock fell this past week, investors looked beyond headline results to the quality of communication from...
This article dives into amerisafe (amsf) 2025 earnings expectations, outlining key drivers, potential pitfalls, and a...
A high-profile move by a Palantir insider is sparking debate about valuations, AI stock exposure, and the road ahead ...
Investors often react to headlines about Coinbase and Circle with a knee-jerk fear or optimism. This piece explains w...
Micron stock has surged on AI tailwinds, but powerful under-the-radar forces could extend the rally. This article exp...